Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Serum Tau-217 for POCD in Elderly
NCT06366412Phase 4Recruiting
- Sponsor
- Minia University Hospital
- Start
- Apr 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Post-operative cognitive dysfunction (POCD) comparing Dexmedetomidine Group with Placebo Group (2 arms). Primary endpoint: Serum Tau-217 protein value at 2 years. Started Apr 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT06366412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06366412.